Prostate-specific membrane antigen positron emission tomography-computed tomography for prostate cancer: distribution of disease and implications for radiation therapy planning

- Gupta, Sandeep K., Watson, Tahne, Denham, Jim, Shakespeare, Thomas P., Rutherford, Natalie, McLeod, Nicholas, Picton, Kevin, Ainsworth, Paul, Bonaventura, Tony, Martin, Jarad M.

Proteins Annexin A2 and PSA in prostate cancer biopsies do not predict biochemical failure

- Lamb, David S., Sondhauss, Sven, Dunne, Jonathan C., Woods, Lisa, Delahunt, Brett, Ferguson, Peter, Murray, Judith, Nacey, John N., Denham, James W., Jordan, T. William

Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement

- Legge, Kimberley, Greer, Peter B., O'Connor, Daryl J., Wilton, Lee, Richardson, Matthew, Hunter, Perry, Wilfert, Alex, Martin, Jarad, Rosenfeld, Anatoly, Cutajar, Dean

Regression and statistical shape model based substitute CT generation for MRI alone external beam radiation therapy from standard clinical MRI sequences

- Ghose, Soumya, Greer, Peter B., Best, Leah, Dowling, Jason A., Sun, Jidi, Pichler, Peter, Rivest-Henault, David, Mitra, Jhimli, Richardson, Haylea, Wratten, Chris, Martin, Jarad, Arm, Jameen

Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications

- Moulton, Calyn R., House, Michael J., Lye, Victoria, Tang, Colin I., Krawiec, Michele, Joseph, David J., Denham, James W., Ebert, Martin A.

Spinal cord injuries and nerve dependence in prostate cancer

- Rutledge, Alison, Jobling, Phillip, Walker, Marjorie M., Denham, Jim W., Hondermarck, Hubert

Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data

- Luo, Qingwei, Egger, Sam, Yu, Xue Qin, Smith, David P., O'Connell, Dianne L.

A novel feature selection approach for data integration analysis: applications to transcriptomics study

- Puthiyedth, Nisha

Decision-making in prostate cancer: active surveillance over other treatment options

- Bayliss, David, Duff, Jed, Stricker, Phil, Walker, Kim

Gleason score and the risk of cause-specific and all-cause mortality following radiation with or without 6 months of androgen deprivation therapy for men with unfavorable-risk prostate cancer

- Warren, Laura E. G., Chen, Ming-Hui, Denham, James W., Steigler, Allison B., Renshaw, Andrew A., Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.

Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: results from a large pooled population

- Cicchetti, A., Rancati, T., Avuzzi, B., Stucchi, C., Valdagni, R., Ebert, M., Fiorino, C., Palorini, F., Kennedy, A., Joseph, D. J., Denham, J. W., Vavassori, V., Fellin, G.

MRI-alone radiation therapy planning for prostate cancer: automatic fiducial marker detection

- Ghose, Soumya, Mitra, Jhimli, Rivest-Hénault, David, Fazlollahi, Amir, Stanwell, Peter, Pichler, Peter, Sun, Jidi, Fripp, Jurgen, Greer, Peter B., Dowling, Jason A.

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial

- Schofield, Penelope, Gough, Karla, Duchesne, Gillian, Sanson-Fisher, Rob, Aranda, Sanchia, Lotfi-Jam, Kerryann, Bergin, Rebecca, Ugalde, Anna, Dudgeon, Paul, Crellin, Wallace, Schubach, Kathryn, Foroudi, Farshard, Tai, Keen Hun

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)

- Louie-Johnsun, Mark William, Handmer, Marcus M., Calopedos, Ross John Spero, Chabert, Charles, Cohen, Ronald J., Gianduzzo, Troy R. J., Kearns, Paul A., Moon, Daniel A., Ooi, Jason, Shannon, Tom, Sofield, David, Tan, Andrew H. H.

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

- Duchesne, Gillian M., Woo, Henry H., Millar, Jeremy, Milne, Roger, Smith, Rosemary G., Spry, Nigel, Stockler, Martin, Syme, Rodney A., Tai, Keen Hun, Turner, Sandra, Bassett, Julie K., Bowe, Steven J., D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn

A new combinatorial optimization approach for integrated feature selection using different datasets: a prostate cancer transcriptomic study

- Puthiyedth, Nisha, Riveros, Carlos, Berretta, Regina, Moscato, Pablo

A population-based study of progression to metastatic prostate cancer in Australia

- Luo, Qingwei, Yu, Xue Qin, Smith, David Paul, O'Connell, Dianne Lesley

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial

- Cormie, Prue, Galvão, Daniel A., Spry, Nigel, Joseph, David, Chee, Raphael, Taaffe, Dennis R., Chambers, Suzanne K., Newton, Robert U.

Comparing volumetric modulated arc therapy to intensity modulated radiation therapy for the treatment of early stage prostate cancer

- Elith, Craig Anthony